INTESTINAL BARRIER DYSFUNCTION AND CONTROL OF ENDOGENOUS INTOXICATION IN ACUTE PANCREATITIS: OPPORTUNITIES FOR INTEGRATING ENTEROSORPTION INTO A CLINICAL ALGORITHM
Keywords:
acute pancreatitis, intestinal barrier, endogenous intoxication, endotoxemia, cytokines, enterosorptionAbstract
Background. Severe acute pancreatitis is driven not only by local pancreatic injury but also by systemic mediator release, impaired intestinal barrier integrity, and translocation of microbial products. Objective. To structure endogenous intoxication mechanisms along the pancreas-gut-systemic inflammation axis and define the potential role and limitations of enterosorption in multimodal care. Materials and methods. Eighteen key sources published in 2000-2026, including clinical guidelines, systematic reviews, experimental studies, and clinical reports, were assessed using a structured analytical approach. Results. Four linked components were identified: acinar injury, dysregulated mediator response, intestinal barrier failure, and secondary systemic endotoxemia. Sorbent binding of bacterial toxins and selected inflammatory mediators is mechanistically plausible; however, high-quality clinical evidence that oral enterosorption reduces mortality, organ failure, or infected necrosis is insufficient. Conclusion. Enterosorption cannot replace guideline-based fluid, nutritional, and etiologic treatment. It may be considered only as an adjunct in selected patients with preserved intestinal function and no contraindications, preferably within a research protocol or a locally approved clinical pathway.
References
1.Мусашайхов Х.Т., Косимов А.Л., Салохиддинов К.З., Мусашайхов У.Х., Мирзаев К.К. Современные взгляды на проблему эндогенной интоксикации при остром панкреатите и выбор патогенетически обоснованной дезинтоксикационной терапии (обзор литературы) // Journal of Modern Medicine. 2026. №1(12), т.1. С.197-209.
2.Tenner S., Vege S.S., Sheth S.G. et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis // Am J Gastroenterol. 2024. Vol.119(3). P.419-437. doi:10.14309/ajg.0000000000002645.
3.Page M.J., McKenzie J.E., Bossuyt P.M. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews // BMJ. 2021. Vol.372. n71. doi:10.1136/bmj.n71.
4.Habtezion A., Gukovskaya A.S., Pandol S.J. Acute Pancreatitis: A Multifaceted Set of Organelle and Cellular Interactions // Gastroenterology. 2019. Vol.156(7). P.1941-1950. doi:10.1053/j.gastro.2018.11.082.
5.Szatmary P., Grammatikopoulos T., Cai W. et al. Acute Pancreatitis: Diagnosis and Treatment // Drugs. 2022. Vol.82(12). P.1251-1276. doi:10.1007/s40265-022-01766-4.
6.van den Berg F.F., de Bruijn A.C., van Santvoort H.C. et al. Early laboratory biomarkers for severity in acute pancreatitis: a systematic review and meta-analysis // Pancreatology. 2020. Vol.20(7). P.1302-1311.
7.Li X.Y., He C., Zhu Y., Lu N.H. Role of gut microbiota on intestinal barrier function in acute pancreatitis // World J Gastroenterol. 2020. Vol.26(18). P.2187-2193. doi:10.3748/wjg.v26.i18.2187.
8.Ge P., Luo Y., Okoye C.S. et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis // Biomed Pharmacother. 2020. Vol.132. 110770. doi:10.1016/j.biopha.2020.110770.
9.Schietroma M., Pessia B., Carlei F. et al. Intestinal permeability and systemic endotoxemia in patients with acute pancreatitis // Ann Ital Chir. 2016. Vol.87. P.138-144.
10.Howell C.A., Mikhalovsky S.V., Markaryan E.N., Khovanov A.V. Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs // Sci Rep. 2019. Vol.9. 5629. doi:10.1038/s41598-019-42176-z.
11.Tomescu D., Popescu M., David C., Dima S. Clinical effects of hemoadsorption with CytoSorb in patients with severe acute pancreatitis: a case series // Int J Artif Organs. 2019. Vol.42(4). P.190-193. doi:10.1177/0391398818823762.
12.Kogelmann K., Jarczak D., Scheller M., Drüner M. Hemoadsorption by CytoSorb in septic patients: a case series // Crit Care. 2017. Vol.21. 74. doi:10.1186/s13054-017-1662-9.
13.Shen Q.X., Xu G.X., Shen M.H. Effect of early enteral nutrition on endotoxin in serum and intestinal permeability in patients with severe acute pancreatitis // Eur Rev Med Pharmacol Sci. 2017. Vol.21(11). P.2764-2768.
14.Tanaka T., Narazaki M., Masuda K., Kishimoto T. Regulation of IL-6 in Immunity and Diseases // Adv Exp Med Biol. 2016. Vol.941. P.79-88. doi:10.1007/978-94-024-0921-5_4.
15.Ronco C., Brendolan A., Dan M. et al. Adsorption in sepsis // Kidney Int Suppl. 2000. Vol.76. P.S148-S155.
16.Naka K., Watarai S., Tana et al. Adsorption effect of activated charcoal on enterohemorrhagic Escherichia coli // J Vet Med Sci. 2001. Vol.63(3). P.281-285.
17.Zhang J., Peng Z., Maberry D. et al. Effects of hemoadsorption with a novel adsorbent on sepsis: in vivo and in vitro study // Blood Purif. 2015. Vol.39(1-3). P.239-245. doi:10.1159/000381098.
18.Banks P.A., Bollen T.L., Dervenis C. et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus // Gut. 2013. Vol.62(1). P.102-111. doi:10.1136/gutjnl-2012-302779.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal